Share
|
Copy Link
https://eyewire.news/tv/eyewire-tv-november-30th-2022
https://eyewire.news/tv/aldeyra-therapeutics-submits-nda-for-reproxalap-for-signs-and-symptoms-of-ded
https://eyewire.news/tv/alcon-completes-acquisition-of-aerie-pharmaceuticals
https://eyewire.news/tv/kala-submits-investigational-nda-for-kpi-012-for-the-treatment-of-rare-corneal-defect